Identification of urine biomarkers of endometriosis—Protein mass spectrometry

Alenka Višnić,Dubravko Barišić,Gordana Čanadi Jurešić,Tina Sušanj Šepić,Neda Smiljan Severinski

DOI: https://doi.org/10.1111/aji.13856

2024-05-08

American Journal of Reproductive Immunology

Abstract:Introduction Endometriosis is a chronic inflammatory disease that leads to a series of pathological reactions. The basis is a changed proinflammatory activated immune system, which results in more pronounced oxidative stress, disturbed function of proteolysis and cell apoptosis. These processes are crucial in the development of the disease because their dysfunctional activities cause the progression of the disease. It is believed that the proteins excreted in the urine interact with each other and promote pathological processes in endometriosis. Methods We analyzed the urine proteome of patients and aimed to detect a potential protein biomarker for endometriosis in the urine proteome. We collected urine samples from 16 patients with endometriosis and 16 patients in the control group with functional ovarian cysts. The diagnosis for all patients was confirmed through pathohistological analysis. After the preanalytical preparation of the urine, chromatography and mass spectrometry (LC‐MS/MS) used the technology of urine proteome analysis. Results The main finding was a significantly different concentration of 14 proteins in the urine samples. We recorded a considerably higher concentration of proteins that have a significant role in activating the immune system (SELL), iron metabolism (HAMP) and cell apoptosis (CHGA) in endometriosis compared to controls. Proteins having an antioxidant function (SOD1) and a role in proteolysis of the extracellular matrix (MMP‐9) were significantly reduced in endometriosis compared to controls. Conclusion Consistent with the known pathogenesis of endometriosis, the study results complement the pathological responses that occur with disease progression.

immunology,reproductive biology